SOMERSET N.J. (BUSINESS WIRE) On Wednesday 24th April 2024 BAP Pharma hosted the Grand Opening Ceremony for its new US headquarters in Somerset NJ.
The weather could not have been better for an exciting day of events as BAP Pharma welcomed guests and dignitaries to the Grand Opening Ceremony of its new headquarters on Randolph Road.
In attendance were BAP Pharma executives and employees, dignitaries including Mary Stahl, Head Key Accounts and Projects, Life Sciences from the British Consulate General New York, and BAP Pharma customers, both old and new.
Events started with a fully catered ‘Meet and Greet’ followed by guided facility tours by BAP Pharma executives and employees to showcase BAP Pharma’s operations and the new and expanded features and capabilities.
Commemorative speeches were given by Sara Sooy, Somerset County Commissioner Deputy Director, Chris Edwards, Somerset County Business Partnership, President & CEO, and Tom Skiendzielewski, General Manager of BAP Pharma US. The speeches were followed by the formal ribbon cutting by Mrs. Nafisa Parkar, BAP Pharma Director.
Established in 2011 by Dr. Bashir Parkar, Founder and Managing Director, BAP Pharma provides the high-quality supply of comparator drugs for clinical trials to help overcome the common barriers to treatment for patients. By providing a global solution as a top-tier service provider, BAP Pharma delivers medicines to patients at the right time, at the right place and at the right temperature.
BAP Pharma’s new US Headquarters are fully licensed by the New Jersey State Department of Health and are in a modern, state-of-the-art 28,000 sq. ft facility with capabilities that include a 24-hour temperature-controlled and monitored warehouse with ambient (+15°C to +25°C), cold (+2°C to +8°C), and freezer (-20°C) storage facilities. Additionally, BAP Pharma’s new US facility can provide in-house label design and print, temperature-controlled clinical secondary packaging, and just-in-time/on-demand labelling.
BAP Pharma recently formed two new divisions – ‘Clinical Secondary Packaging & Labelling‘ and ‘Medicines Access‘ to complement the original ‘Comparator Sourcing‘ business, necessitating the move to a much larger facility with a broader range of capabilities.
